Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Glucosamine sulfate + meloxicam** is a fixed-dose combination of two agents: - **Glucosamine sulfate** is an amino sugar and precursor in the biochemical synthesis of glycosylated proteins and lipids, used as a dietary supplement and for the symptomatic management of osteoarthritis. It is thought to help repair and regenerate degenerated cartilage by inhibiting cartilage-degrading enzymes and suppressing oxidative stress, with some evidence for pain relief and improved joint function. - **Meloxicam** is a non-steroidal anti-inflammatory drug (NSAID), specifically a preferential cyclooxygenase-2 (COX-2) inhibitor, with anti-inflammatory, analgesic, and antipyretic properties. It reduces pain and inflammation primarily by inhibiting COX-2 and, to a lesser extent, COX-1, thus reducing prostaglandin synthesis. The combination has been studied as a treatment for knee osteoarthritis, where studies suggest it is more effective than meloxicam alone in reducing pain, clinical symptoms, and markers of cartilage degradation, with an overall good tolerability profile and mild, self-limiting adverse events[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucosamine sulfate + meloxicam.